Reply to Marchiò et al.: Antitumor immune regulation by angiostatic therapy.
作者信息
Wentink Madelon Q, Huijbers Elisabeth J M, Timmerman Peter, Griffioen Arjan W
机构信息
Angiogenesis Laboratory, Department of Medical Oncology, Vrije Universiteit Medical Center, 1081 HZ Amsterdam, The Netherlands.
Van't Hoff Institute of Molecular Sciences, University of Amsterdam, 1098 HX Amsterdam, The Netherlands;
出版信息
Proc Natl Acad Sci U S A. 2017 Apr 18;114(16):E3166-E3167. doi: 10.1073/pnas.1703074114. Epub 2017 Apr 11.
Abstract
摘要
相似文献
1
Reply to Marchiò et al.: Antitumor immune regulation by angiostatic therapy.对马尔乔等人的回复：血管生成抑制疗法的抗肿瘤免疫调节
Proc Natl Acad Sci U S A. 2017 Apr 18;114(16):E3166-E3167. doi: 10.1073/pnas.1703074114. Epub 2017 Apr 11.
2
Angiostatic activity of steroids in the chick embryo CAM and rabbit cornea models of neovascularization.类固醇在鸡胚绒毛尿囊膜和兔角膜新生血管模型中的血管生成抑制活性。
J Ocul Pharmacol Ther. 1999 Oct;15(5):413-23. doi: 10.1089/jop.1999.15.413.
3
Mechanism of action of the angiostatic cortisene anecortave acetate.血管抑制性皮质激素醋酸阿奈可他的作用机制。
Surv Ophthalmol. 2007 Jan;52 Suppl 1:S26-34. doi: 10.1016/j.survophthal.2006.11.003.
4
Antiangiogenesis therapy for endometriosis.子宫内膜异位症的抗血管生成治疗。
J Clin Endocrinol Metab. 2004 Mar;89(3):1089-95. doi: 10.1210/jc.2003-031406.
5
Role of the tumor stroma in resistance to anti-angiogenic therapy.肿瘤基质在抗血管生成治疗中的作用。
Drug Resist Updat. 2016 Mar;25:26-37. doi: 10.1016/j.drup.2016.02.002. Epub 2016 Feb 24.
6
Reply to Ciccolini et al.: Using mathematical modeling to predict response to antiangiogenic therapy in cancer patients.对西科利尼等人的回复：利用数学建模预测癌症患者对抗血管生成疗法的反应。
Proc Natl Acad Sci U S A. 2015 Jul 7;112(27):E3454. doi: 10.1073/pnas.1507225112. Epub 2015 Jun 16.
7
Molecular pathways of angiogenesis inhibition.血管生成抑制的分子途径。
Biochem Biophys Res Commun. 2007 Mar 30;355(1):1-5. doi: 10.1016/j.bbrc.2007.01.123. Epub 2007 Jan 30.
8
A surrogate marker to monitor angiogenesis at last.终于有一个监测血管生成的替代标志物了。
Cancer Cell. 2005 Jan;7(1):3-4. doi: 10.1016/j.ccr.2004.12.014.
9
Multifocal angiostatic therapy: an update.多焦点血管生成抑制疗法：最新进展
Integr Cancer Ther. 2005 Dec;4(4):301-14. doi: 10.1177/1534735405282475.
10
Inhibition of angiogenesis by interleukin-4 gene therapy in rat adjuvant-induced arthritis.白细胞介素-4基因疗法对大鼠佐剂性关节炎血管生成的抑制作用
Arthritis Rheum. 2006 Aug;54(8):2402-14. doi: 10.1002/art.22034.
本文引用的文献
1
An antivascular vaccine to boost self-immunity and strike the tumor.一种增强自身免疫力并对抗肿瘤的抗血管疫苗。
Proc Natl Acad Sci U S A. 2017 Apr 18;114(16):E3164-E3165. doi: 10.1073/pnas.1701452114. Epub 2017 Apr 11.
2
The revival of cancer vaccines - The eminent need to activate humoral immunity.癌症疫苗的复兴——激活体液免疫的迫切需求。
Hum Vaccin Immunother. 2017 May 4;13(5):1112-1114. doi: 10.1080/21645515.2016.1276140. Epub 2017 Jan 24.
3
Targeted vaccination against the bevacizumab binding site on VEGF using 3D-structured peptides elicits efficient antitumor activity.使用三维结构肽针对血管内皮生长因子（VEGF）上贝伐单抗结合位点进行靶向疫苗接种可引发有效的抗肿瘤活性。
Proc Natl Acad Sci U S A. 2016 Nov 1;113(44):12532-12537. doi: 10.1073/pnas.1610258113. Epub 2016 Oct 17.
4
Vaccination approach to anti-angiogenic treatment of cancer.癌症抗血管生成治疗的疫苗接种方法。
Biochim Biophys Acta. 2015 Apr;1855(2):155-71. doi: 10.1016/j.bbcan.2015.01.005. Epub 2015 Jan 30.
5
Enhancement of T-cell-mediated antitumor response: angiostatic adjuvant to immunotherapy against cancer.增强 T 细胞介导的抗肿瘤反应：免疫治疗癌症的血管生成抑制剂佐剂。
Clin Cancer Res. 2011 May 15;17(10):3134-45. doi: 10.1158/1078-0432.CCR-10-2443. Epub 2011 Jan 20.
6
Anti-angiogenesis: making the tumor vulnerable to the immune system.抗血管生成：使肿瘤易受免疫系统攻击。
Cancer Immunol Immunother. 2008 Oct;57(10):1553-8. doi: 10.1007/s00262-008-0524-3. Epub 2008 Apr 26.
7
Anti-angiogenesis therapy can overcome endothelial cell anergy and promote leukocyte-endothelium interactions and infiltration in tumors.抗血管生成疗法可克服内皮细胞无反应性，并促进肿瘤中白细胞与内皮细胞的相互作用和浸润。
FASEB J. 2006 Apr;20(6):621-30. doi: 10.1096/fj.05-4493com.
8
9
Fingerprinting the circulating repertoire of antibodies from cancer patients.对癌症患者循环抗体库进行指纹识别。
Nat Biotechnol. 2003 Jan;21(1):57-63. doi: 10.1038/nbt774. Epub 2002 Dec 23.
Zotero 插件